Advances in intravenous thrombolytic therapy for treatment of acute stroke

Neurology

Volumn 57, Issue 5 SUPPL. 2, 2001, Pages

  Albers, G W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035845652     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.57.suppl_2.s77     Document Type: Article

References (37)

1. Tissue plasminogen activator for acute ischemic stroke
2. Practice advisory: Thrombolytic therapy for acute ischemic stroke - Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology
3. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association
4. Antithrombotic and thrombolytic therapy for ischemic stroke
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
6. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
7. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
8. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial
9. Prospective, monitored, multicenter, post-approval experience with intravenous t-PA for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study
10. Intra-arterial prourokinase for acute ischemic stroke. PROACT II study: A randomized controlled trial
11. New magnetic resonance techniques for acute ischemic stroke
12. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke
13. A new method to improve in-bore middle cerebral artery occlusion in rats: Demonstration with diffusion- and perfusion-weighted imaging
14. Early detection of regional cerebral ischemia in cats: Comparison of diffusion-and T2-weighted MRI and spectroscopy
15. Diffusion-weighted MR imaging of acute stroke: Correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats
16. Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury
17. The application of magnetic resonance imaging to the study of experimental cerebral ischaemia
18. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection
19. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging
20. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: Relation to clinical outcome
21. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: A preliminary analysis
22. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke
23. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction
24. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome
25. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI
26. Contrast agents in functional MR imaging
27. Diffusion and perfusion imaging techniques
28. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke
29. Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion
30. The evolution of acute stroke recorded by multimodal magnetic resonance imaging
31. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI
32. Patterns and frequency of acute ischemic stroke topography as depicted by combined perfusion- and diffusion-weighted magnetic resonance imaging
33. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
34. Thrombolytic reversal of acute human cerebral ischemic injury demonstrated by diffusion/perfusion magnetic resonance imaging
35. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis - Not a panacea for ischemic stroke
36. Stroke thrombolysis - Growing pains
37. Thrombolysis in acute ischemic stroke: Does it work?